Michael Wilkinson Publications

1. Immune-Mediated Inflammatory Diseases, Dyslipidemia, and Cardiovascular Risk: A Complex Interplay
   Wilkinson MJ, Shapiro MD.
   Arterioscler Thromb Vasc Biol. 2024 Dec;44(12):2396-2406. doi: 10.1161/ATVBAHA.124.319983. Epub 2024 Oct 31.

2. Burden of atherogenic lipids and association with cardiac allograft vasculopathy in heart transplant recipients()
   Birs AS, Kao AS, Silver E, Adler ED, Taub PR, Wilkinson MJ.
   J Clin Lipidol. 2024 Nov 13:S1933-2874(24)00263-0. doi: 10.1016/j.jacl.2024.10.005. Online ahead of print.

3. Time-Restricted Eating in Adults With Metabolic Syndrome : A Randomized Controlled Trial
   Manoogian ENC, Wilkinson MJ, O'Neal M, Laing K, Nguyen J, Van D, Rosander A, Pazargadi A, Gutierrez NR, Fleischer JG, Golshan S, Panda S, Taub PR.
   Ann Intern Med. 2024 Nov;177(11):1462-1470. doi: 10.7326/M24-0859. Epub 2024 Oct 1.

4. Unique features of dyslipidemia in women across a lifetime and a tailored approach to management
   Patel N, Mittal N, Wilkinson MJ, Taub PR.
   Am J Prev Cardiol. 2024 Apr 5;18:100666. doi: 10.1016/j.ajpc.2024.100666. eCollection 2024 Jun.

5. A focused update to the 2019 NLA scientific statement on use of lipoprotein(a) in clinical practice
   Koschinsky ML, Bajaj A, Boffa MB, Dixon DL, Ferdinand KC, Gidding SS, Gill EA, Jacobson TA, Michos ED, Safarova MS, Soffer DE, Taub PR, Wilkinson MJ, Wilson DP, Ballantyne CM.
   J Clin Lipidol. 2024 May-Jun;18(3):e308-e319. doi: 10.1016/j.jacl.2024.03.001. Epub 2024 Apr 1.

6. Harnessing RNA Interference for Cholesterol Lowering: The Bench-to-Bedside Story of Inclisiran
   Wilkinson MJ, Bajaj A, Brousseau ME, Taub PR.
   J Am Heart Assoc. 2024 Mar 19;13(6):e032031. doi: 10.1161/JAHA.123.032031. Epub 2024 Mar 8.

7. Time-Restricted Eating: A Novel Dietary Strategy for Cardiac Rehabilitation
   Small S, Iglesies-Grau J, Gariepy C, Wilkinson M, Taub P, Kirkham A.
   Can J Cardiol. 2023 Nov;39(11S):S384-S394. doi: 10.1016/j.cjca.2023.09.017. Epub 2023 Sep 20.

8. Is Lipoprotein(a) Clinically Actionable with Today's Evidence? The Answer is Yes
   Ma GS, Chiou TT, Wilkinson MJ.
   Curr Cardiol Rep. 2023 Oct;25(10):1175-1187. doi: 10.1007/s11886-023-01937-z. Epub 2023 Aug 26.

9. Evolving Management of Low-Density Lipoprotein Cholesterol: A Personalized Approach to Preventing Atherosclerotic Cardiovascular Disease Across the Risk Continuum
   Wilkinson MJ, Lepor NE, Michos ED.
   J Am Heart Assoc. 2023 Jun 6;12(11):e028892. doi: 10.1161/JAHA.122.028892. Epub 2023 Jun 1.

10. Trends in LDL-C following coronary angiography involving assessment by fractional flow reserve in obstructive vs non-obstructive coronary artery disease
    Wilkinson MJ, Xu I, Vasudevan RS, You H, Xu R, Taub PR.
    Am J Prev Cardiol. 2023 Feb 13;13:100473. doi: 10.1016/j.ajpc.2023.100473. eCollection 2023 Mar.

11. Inclisiran creates unique opportunities and challenges for patient access to therapy: early experience in a United States Lipid Clinic
    Chiou TT, Tomasi K, Taub PR, Wilkinson MJ.
    J Clin Lipidol. 2023 Jan-Feb;17(1):73-77. doi: 10.1016/j.jacl.2022.10.009. Epub 2022 Nov 1.

12. Lipoprotein(a): Evidence for Role as a Causal Risk Factor in Cardiovascular Disease and Emerging Therapies
    Bhatia HS, Wilkinson MJ.
    J Clin Med. 2022 Oct 13;11(20):6040. doi: 10.3390/jcm11206040.

13. Trends in testing and prevalence of elevated Lp(a) among patients with aortic valve stenosis
    Bhatia HS, Ma GS, Taleb A, Wilkinson M, Kahn AM, Cotter B, Yeang C, DeMaria AN, Patel MP, Mahmud E, Reeves RR, Tsimikas S.
    Atherosclerosis. 2022 May;349:144-150. doi: 10.1016/j.atherosclerosis.2022.01.022. Epub 2022 Jan 31.

14. Ten-Hour Time-Restricted Eating Reduces Weight, Blood Pressure, and Atherogenic Lipids in Patients with Metabolic Syndrome
    Wilkinson MJ, Manoogian ENC, Zadourian A, Lo H, Fakhouri S, Shoghi A, Wang X, Fleischer JG, Navlakha S, Panda S, Taub PR.
    Cell Metab. 2020 Jan 7;31(1):92-104.e5. doi: 10.1016/j.cmet.2019.11.004. Epub 2019 Dec 5.

15. Heart Failure and Diabetes Mellitus: Defining the Problem and Exploring the Interrelationship
    Wilkinson MJ, Zadourian A, Taub PR.
    Am J Cardiol. 2019 Dec 15;124 Suppl 1:S3-S11. doi: 10.1016/j.amjcard.2019.10.024.

16. Lipoprotein(a) in Patients Undergoing Transcatheter Aortic Valve Replacement
    Ma GS, Wilkinson MJ, Reeves RR, Yeang C, DeMaria AN, Cotter B, Patel M, Mahmud E, Tsimikas S.
    Angiology. 2019 Apr;70(4):332-336. doi: 10.1177/0003319719826461. Epub 2019 Jan 30.

17. The Prevalence of Lipoprotein(a) Measurement and Degree of Elevation Among 2710 Patients With Calcific Aortic Valve Stenosis in an Academic Echocardiography Laboratory Setting
    Wilkinson MJ, Ma GS, Yeang C, Ang L, Strachan M, DeMaria AN, Tsimikas S, Cotter B.
    Angiology. 2017 Oct;68(9):795-798. doi: 10.1177/0003319716688415. Epub 2017 Jan 10.

18. Inappropriate ICD Shock From Perceived Ventricular Fibrillation During Balloon Manipulation at the Time of Percutaneous Coronary Intervention
    Pourdjabbar A, Wilkinson MJ, Ang L, Reeves RR, Mahmud E, Patel MP.
    J Invasive Cardiol. 2017 Aug;29(8):E94-E95.

19. Lipoprotein(a) and oxidized phospholipids in calcific aortic valve stenosis
    Yeang C, Wilkinson MJ, Tsimikas S.
    Curr Opin Cardiol. 2016 Jul;31(4):440-50. doi: 10.1097/HCO.0000000000000300.

20. Temple J. L., Sweeney, D. A., Wilkinson, M. J., and L.B. Daniels. May, 2016. An Elderly Woman with Acute Onset Chest Pain. American Thoracic Society, Critical Care Quick Hits Case Report (Online). https://www.thoracic.org/professionals/clinicalresources/critical-care/clinical-education/quick-hits/an-elderly-woman-with-acute-onset-chest-pain.php

21. Wilkinson, M. J., Laffin, L. J., and M. H. Davidson. 2014. Overcoming toxicity and side-effects of lipid lowering therapies. Best Practice and Research Clinical Endocrinology and Metabolism, 28(3): 439-452.

22. Toth, P. P., Shah, P. K., Wilkinson, M. J., Davidson, M. H., and P.A. McCullough. 2014. Use of microsomal triglyceride transfer protein inhibitors in patients with homozygous familial hypercholesterolemia: translating clinical trial experience into clinical practice. Reviews in Cardiovascular Medicine, 15(1): 1-10.

23. Wilkinson, M. J. and M. H. Davidson. 2013. Recent developments in the treatment of familial hypercholesterolemia: a review of several new drug classes. Current Treatment Options in Cardiovascular Medicine, 15(6): 696-705.

24. Wilkinson, M. J., Nathan, A. G., and E. S. Huang. 2013. Personalized decision support in type 2 diabetes mellitus: current evidence and future directions. Current Diabetes Reports, 13(2): 205-212

25. Wilkinson M. J., Yai Y., and D. M. O'Brien. 2007. Age-related variation in red blood cell stable isotope ratios (delta13C and delta 15N) from two Yupik villages in Southwest Alaska: a pilot study. International Journal of Circumpolar Health, 66(1 ): 31-41.

26. O'Brien D. M., Kristal A. R., Jeannet M.A., Wilkinson M. JI., Bersamin A., and B. Luick. 2009. Red blood cell deltal5N: a novel biomarker of dietary eicosapentaenoic acid and docosahexaenoic acid intake. American Journal of Clinical Nutrition, 89(3): 913-919.

Textbooks and Chapters

Manoogian E.N.C., Gutierrez N.R., Padilla E., and M. J. Wilkinson. 2024. Circadian Rhythms and Weight Loss: Timed Food Intake. In: Handbook of Obesity, 5th Edition. CRC Press.

Bhatia, H. S., Xu, I., Taub, P.R., and M. J. Wilkinson. 2022. Ethnic Factors in the Assessment of Cardiovascular Risk for Primary Prevention. In: Shapiro, M. D. (Ed.}, Cardiovascular Risk Assessment in Primary Prevention (Contemporary Cardiology Series). Humana Press.

Wilkinson, M. J. 2021. Cardiovascular Genomics. In: Davidson M.H., Toth P.P., Maki K.C. (Eds.), Therapeutic Lipidology 2" Edition (Contemporary Cardiology Series). Humana, Cham.

Davidson, D. J., Wilkinson, M. J., and M. H. Davidson. 2014. Combination Therapy for Dyslipidemia. In: C. M. Ballantyne (Ed.), Clinical Lipidology: A Companion to Braunwald's Heart Disease 2Edition (pp. 313-325). Philadelphia, PA: Elsevier Saunders